Application Note

Micro-RNA Nanoparticles For Gene Silencing: Measuring Size And Zeta Potential With Light Scattering Technology

Source: Anton Paar USA
Litesizer 500

RNA interference is a highly promising gene silencing technique in which translation of the target gene’s messenger RNA (mRNA) is inhibited by short complementary RNA sequences. These include the so-called small interfering-RNAs (siRNA), which are double-stranded and whose sequence is perfectly complementary to that of the target mRNA, therefore acting with a high degree of specificity, and the single-stranded micro-RNAs (miRNA), which can interfere with a broader range of targets through imperfect pairing.

One of the biggest challenges of RNA interference is the difficulty to deliver intact siRNA/miRNA across the cell membrane and into the cytosol while preserving cell viability. Intracellular delivery of RNA by transfection using peptide-based nanoparticles has shown promise. Such vectors are composed of the negatively charged nucleic acids and positively charged peptides, which co-assemble spontaneously into nanoparticles in solution. The arginine-rich peptide protamine forms nanoparticles that are predicted to exhibit good cell-penetrating properties and lower cytotoxicity than other commercially available transfection reagents.

Since nanoparticle properties such as size and zeta potential may influence particle uptake by target cells and/or tissues in vivo, light scattering technologies represent an important tool to investigate the physicochemical properties of miRNA-delivery systems. Here we demonstrate that the Litesizer™ 500 returns rapid and precise results despite very low sample concentration and volume. We used dynamic light scattering (DLS) for particle size measurement and a novel patented
electrophoretic light scattering technology called cmPALS for zeta potential determination.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online